Kymera Therapeutics Inc (KYMR) — Free Cash Flow Generation Index

Latest as of December 2023: -0.44x

Kymera Therapeutics Inc (KYMR) has a Free Cash Flow Generation Index of -0.44x as of December 2023. Free cash flow of $-3.58 Million represents 0% of operating cash flow ($8.04 Million). See Kymera Therapeutics Inc (KYMR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-0.44x
Free Cash Flow / Operating CF

Free Cash Flow

$-3.58 Million
USD

Operating Cash Flow

$8.04 Million
USD

Capital Expenditures

$11.62 Million
USD

Kymera Therapeutics Inc Free Cash Flow Generation Index (2019–2020)

Historical FCF Generation Index trend for Kymera Therapeutics Inc across 2 annual periods. Explore Kymera Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Kymera Therapeutics Inc (2019–2020)

Year-by-year Free Cash Flow Generation Index for Kymera Therapeutics Inc. For the full company profile including market capitalisation, see Kymera Therapeutics Inc market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.90x $79.03 Million $88.13 Million $9.10 Million ▼ -7.6%
2019 0.97x $17.37 Million $17.91 Million $532.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).